Exchange: NASDAQ·Updated 08:04 PM EST

CRIS News

News
all
press releases
Curis (CRIS) Q3 2026 Earnings Call Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
Curis (CRIS) Q3 2026 Earnings Call Transcript
@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo...
Nasdaq News: Markets
More News
Curis Provides Third Quarter 2026 Business Update Curis Provides Third Quarter 2026 Business UpdatePR NewswireLEXINGTON, Mass., Nov. 12, 2026 Management to host conference call and webcast today at 4:30 p.m. ETLEXINGTON, Mass., Nov. 12, 2026 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a...
PR Newswire
Curis to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on November 12, 2026 Curis to Report Third Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast on November 12, 2026PR NewswireLEXINGTON, Mass., Nov. 5, 2026...
PR Newswire
Gainers Curis (NASDAQ:CRIS) shares moved upwards by 61.8% to $1.16 during Wednesday's regular session. The market value of their outstanding shares is at $1.7 million. Lyell Immunopharma (NASDAQ:LYEL) shares movedread more...
Benzinga
Gainers Curis (NASDAQ:CRIS) stock moved upwards by 83.5% to $1.31 during Wednesday's pre-market session. The company's market cap stands at $1.7 million. SCWorx (NASDAQ:WORX) stock increased by 13.28% toread more...
Benzinga
Limbach surged 14.7% after beating Q3 estimates and raising FY26 sales guidance; Curis gained 69.5%, while Cenntro plunged 46.5%.read more...
Benzinga
Gainers Curis (NASDAQ:CRIS) stock increased by 25.6% to $0.83 during Tuesday's regular session. The company's market cap stands at $1.6 million. Pasithea Therapeutics (NASDAQ:KTTA) shares increased by 22.28%read more...
Benzinga
Curis, Inc. Announces Pricing of $8.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules with Existing Healthcare Focused Institutional Investors Curis, Inc. Announces Pricing of $8.5 Million Private Placement Priced At-the-Market Under Nasdaq Rules with Existing Healthcare Focused...
PR Newswire
Curis, Inc. Announces Pricing of $5.6 Million Public Offering Curis, Inc. Announces Pricing of $5.6 Million Public Offering PR Newswire LEXINGTON, Mass., Aug. 13, 2026 LEXINGTON, Mass., Aug. 13, 2026 /PRNewswire/ -- Curis, Inc. (Nasdaq: CRIS), a biotechnology company focused on the development of...
PR Newswire
Curis Doses First Five Patients in TakeAim CLL Study Curis Doses First Five Patients in TakeAim CLL Study PR Newswire LEXINGTON, Mass., July 30, 2026 LEXINGTON, Mass., July 30, 2026 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib...
PR Newswire

Advertisement|Remove ads.